Brian Andrew Van Tine, MD, PhD (he/him/his)
Professor of Medicine
Washington University School of Medicine
St. Louis, Missouri, United States
Berkley E. Gryder, PhD
Case Western Reserve University
Cleveland, Ohio, United States
Jonathan Nakashima, PhD
Certis Oncology
San Diego, California, United States
Monica M. Mita, MD
Cedars-Sinai, Samuel Oschin Cancer Center
Los Angeles, California, United States
Alain C. Mita, MD
Cedars-Sinai, Samuel Oschin Cancer Center
Los Angeles, California, United States
Noah Federman, MD
Professor
David Geffen School of Medicine, University of California, Los Angeles
Los Angeles, California, United States
Drew W. Rasco, MD
START Center for Cancer Care
San Antonio, Texas, United States
David Spigel, MD
Sarah Cannon Research Institute at Tennessee Oncology
Nashville, Tennessee, United States
Jia Luo, MD
Instructor
Dana-Farber Cancer Institute
Boston, Massachusetts, United States
Diana H. Chin, BS
Case Western Reserve University
Cleveland, Ohio, United States
Gregory M. Cote, MD, PhD (he/him/his)
Assistant Professor
Mass General Cancer Center
Boston, Massachusetts, United States
Richard E. Cutler, Jr., PhD (he/him/his)
Vice President
Kronos Bio
San Mateo, California, United States
Pavan Kumar, PhD
Kronos Bio
Cambridge, Massachusetts, United States
Tressa R. Hood, MS (she/her/hers)
Associate Director Translation Data
Kronos Bio
Cambridge, Massachusetts, United States
Luis A. Carvajal, PhD
Kronos Bio
San Mateo, California, United States
Crystal J. MacKenzie, BS
Kronos Bio
San Mateo, California, United States
Charles Y. Lin, PhD
Kronos Bio
Cambridge, Massachusetts, United States
Jorge F. DiMartino, MD, PhD (he/him/his)
Chief Medical Officer, Executive VP Clinical Development
Kronos Bio
San Mateo, California, United States
Elizabeth A. Olek, DO, MPH
Clinical Development
Kronos Bio
San Mateo, California, United States
Miguel A. Villalona-Calero, MD (he/him/his)
Director Early Therapeutics
City of Hope National Medical Center
Duarte, California, United States
